IRAK inhibitor 4,
1012104-68-5,
IRAK inhibitor 4 (trans),
1-(4-hydroxycyclohexyl)-N-(3-methylbutyl)-2-[[5-[2-(trifluoromethoxy)phenyl]-1H-indazol-3-yl]amino]benzimidazole-5-carboxamide,
SCHEMBL2031737,
DTXSID40647337,
C33H35F3N6O3,
BCP26327,
3746AH,
HY-13278A,
ZINC73096248,
AKOS030526198,
AKOS032944993,
ZINC100014647,
ZINC253387931,
BCP9000040,
CS-0606,
CS-3473,
NCGC00390557-01,
HY-13278,
W-5875,
1-((1r,4r)-4-hydroxycyclohexyl)-N-isopentyl-2-(5-(2-(trifluoromethoxy)phenyl)-1H-indazol-3-ylamino)-,
1-(4-Hydroxycyclohexyl)-N-(3-methylbutyl)-2-({5-[2-(trifluoromethoxy)phenyl]-1H-indazol-3-yl}amino)-1H-benzimidazole-5-carboxamide,
2070014-89-8,
IRAK inhibitor 4 trans,
A3503,